WallStSmart

Amrize Ltd (AMRZ)vsKnife River Corporation (KNF)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Amrize Ltd generates 276% more annual revenue ($11.81B vs $3.15B). AMRZ leads profitability with a 10.0% profit margin vs 5.0%. AMRZ appears more attractively valued with a PEG of 1.40. KNF earns a higher WallStSmart Score of 61/100 (C+).

AMRZ

Buy

55

out of 100

Grade: C-

Growth: 3.3Profit: 6.5Value: 7.3Quality: 5.8
Piotroski: 3/9

KNF

Buy

61

out of 100

Grade: C+

Growth: 7.3Profit: 5.5Value: 10.0Quality: 6.3
Piotroski: 3/9Altman Z: 2.77
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AMRZSignificantly Overvalued (-119.3%)

Margin of Safety

-119.3%

Fair Value

$26.88

Current Price

$56.12

$29.24 premium

UndervaluedFair: $26.88Overvalued
KNFUndervalued (+37.6%)

Margin of Safety

+37.6%

Fair Value

$129.17

Current Price

$87.90

$41.27 discount

UndervaluedFair: $129.17Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMRZ2 strengths · Avg: 8.0/10
Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$1.65B8/10

Generating 1.6B in free cash flow

KNF1 strengths · Avg: 8.0/10
EPS GrowthGrowth
36.1%8/10

Earnings expanding 36.1% YoY

Areas to Watch

AMRZ4 concerns · Avg: 3.3/10
P/E RatioValuation
25.9x4/10

Moderate valuation

EPS GrowthGrowth
3.6%4/10

3.6% earnings growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Revenue GrowthGrowth
-0.4%2/10

Revenue declined 0.4%

KNF4 concerns · Avg: 3.5/10
PEG RatioValuation
1.654/10

Expensive relative to growth rate

P/E RatioValuation
31.1x4/10

Premium valuation, high expectations priced in

Profit MarginProfitability
5.0%3/10

5.0% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : AMRZ

The strongest argument for AMRZ centers on Price/Book, Free Cash Flow. PEG of 1.40 suggests the stock is reasonably priced for its growth.

Bull Case : KNF

The strongest argument for KNF centers on EPS Growth. Revenue growth of 14.9% demonstrates continued momentum.

Bear Case : AMRZ

The primary concerns for AMRZ are P/E Ratio, EPS Growth, Piotroski F-Score.

Bear Case : KNF

The primary concerns for KNF are PEG Ratio, P/E Ratio, Profit Margin. Thin 5.0% margins leave little buffer for downturns.

Key Dynamics to Monitor

KNF is growing revenue faster at 14.9% — sustainability is the question.

AMRZ generates stronger free cash flow (1.6B), providing more financial flexibility.

Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

KNF scores higher overall (61/100 vs 55/100) and 14.9% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Amrize Ltd

BASIC MATERIALS · BUILDING MATERIALS · USA

Amrize Ltd (AMRZ) is an innovative technology company at the forefront of the digital health and wellness sector, striving to transform healthcare delivery through advanced technologies and data-driven solutions. With a strong emphasis on enhancing patient outcomes and increasing healthcare accessibility, Amrize engages in extensive research and development to address the growing demand for scalable health solutions. The company’s strategic initiatives position it to play a pivotal role in the evolving landscape of healthcare, making it a critical player in the advancement of modern healthcare systems.

Visit Website →

Knife River Corporation

BASIC MATERIALS · BUILDING MATERIALS · USA

Knife River Corporation provides aggregates-based construction materials and contracting services in the United States. The company is headquartered in Bismarck, North Dakota.

Want to dig deeper into these stocks?